Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in March
Pacira BioSciences (Nasdaq: PCRX), a leader in non-opioid pain therapies, has announced its participation in two major healthcare conferences in March 2025. The company will engage in analyst-led fireside chats at:
- The Raymond James 46th Annual Institutional Investors Conference on March 5th at 10:25AM ET
- The Barclays 27th Annual Global Healthcare Conference on March 12th at 8:00AM ET
Both events will be accessible via live audio on the company's website investor.pacira.com under the 'Events' section. Webcasts will remain available for replay for two weeks following each event.
Pacira BioSciences (Nasdaq: PCRX), un leader nelle terapie per il dolore non oppioidi, ha annunciato la sua partecipazione a due importanti conferenze sanitarie nel marzo 2025. L'azienda parteciperà a conversazioni informali guidate da analisti presso:
- La 46ª Conferenza Annuale degli Investitori Istituzionali di Raymond James il 5 marzo alle 10:25 ET
- La 27ª Conferenza Annuale Globale sulla Salute di Barclays il 12 marzo alle 8:00 ET
Entrambi gli eventi saranno accessibili tramite audio in diretta sul sito web dell'azienda investor.pacira.com nella sezione 'Eventi'. Le registrazioni rimarranno disponibili per la visione per due settimane dopo ciascun evento.
Pacira BioSciences (Nasdaq: PCRX), un líder en terapias para el dolor no opioide, ha anunciado su participación en dos importantes conferencias de salud en marzo de 2025. La compañía participará en charlas informales dirigidas por analistas en:
- La 46ª Conferencia Anual de Inversores Institucionales de Raymond James el 5 de marzo a las 10:25 AM ET
- La 27ª Conferencia Global Anual de Salud de Barclays el 12 de marzo a las 8:00 AM ET
Ambos eventos estarán accesibles a través de audio en vivo en el sitio web de la compañía investor.pacira.com en la sección 'Eventos'. Las grabaciones estarán disponibles para su reproducción durante dos semanas después de cada evento.
Pacira BioSciences (Nasdaq: PCRX)는 비오피오이드 통증 치료의 선두주자로서 2025년 3월에 열리는 두 개의 주요 의료 회의에 참여한다고 발표했습니다. 회사는 분석가 주도의 대화에 참여할 예정입니다:
- 레이먼드 제임스 제46회 연례 기관 투자자 회의가 3월 5일 오전 10시 25분 ET에 열립니다.
- 바클레이스 제27회 연례 글로벌 의료 회의가 3월 12일 오전 8시 ET에 열립니다.
두 행사 모두 회사 웹사이트 investor.pacira.com의 '이벤트' 섹션에서 실시간 오디오로 접근할 수 있습니다. 각 이벤트 후 2주 동안 웹캐스트를 다시 볼 수 있습니다.
Pacira BioSciences (Nasdaq: PCRX), un leader dans les thérapies antidouleur non opioïdes, a annoncé sa participation à deux grandes conférences de santé en mars 2025. L'entreprise participera à des discussions informelles dirigées par des analystes lors de :
- La 46e Conférence Annuelle des Investisseurs Institutionnels de Raymond James le 5 mars à 10h25 ET
- La 27e Conférence Annuelle Mondiale de la Santé de Barclays le 12 mars à 8h00 ET
Les deux événements seront accessibles en audio en direct sur le site web de l'entreprise investor.pacira.com dans la section 'Événements'. Les rediffusions seront disponibles pendant deux semaines après chaque événement.
Pacira BioSciences (Nasdaq: PCRX), ein führendes Unternehmen im Bereich nicht-opioider Schmerztherapien, hat seine Teilnahme an zwei wichtigen Gesundheitskonferenzen im März 2025 angekündigt. Das Unternehmen wird an analystengeführten Gesprächen teilnehmen:
- Auf der 46. Jahrestagung der institutionellen Investoren von Raymond James am 5. März um 10:25 Uhr ET
- Auf der 27. Jahrestagung für globale Gesundheitsversorgung von Barclays am 12. März um 8:00 Uhr ET
Beide Veranstaltungen sind über Live-Audio auf der Unternehmenswebsite investor.pacira.com im Bereich 'Veranstaltungen' zugänglich. Die Webcasts werden zwei Wochen nach jeder Veranstaltung zur Wiederholung verfügbar sein.
- None.
- None.
PARSIPPANY, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will participate in an analyst-led fireside chat at the following two healthcare conferences:
- Raymond James 46th Annual Institutional Investors Conference on Wednesday, March 5th at 10:25AM ET.
- Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12th at 8:00AM ET.
Live audio of the events can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcasts will also be available for two weeks following the events.
About Pacira
Pacira delivers innovative, non-opioid pain therapies to transform the lives of patients. Pacira has three commercial-stage non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting local analgesic currently approved for infiltration, fascial plane block, and as an interscalene brachial plexus nerve block, an adductor canal nerve block, and a sciatic nerve block in the popliteal fossa for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain; and ioveraº®, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. The company is also advancing the development of PCRX-201, a novel locally administered gene therapy with the potential to treat large prevalent diseases like osteoarthritis. To learn more about Pacira, visit www.pacira.com.
FAQ
When is Pacira BioSciences (PCRX) presenting at the Raymond James Conference in March 2025?
How can investors access PCRX's healthcare conference presentations in March 2025?
What healthcare conferences will PCRX attend in March 2025?
When is Pacira BioSciences' presentation at the Barclays Healthcare Conference?
